GSK to withdraw blood cancer drug Blenrep from US market Ruchika Sharma22 Nov 2022 4:15 PM ISTGSK said access to Blenrep in other countries where it is marketed is unaffected, including across the European Union.
GSK Pharma shuts its consumer trade channel, impacting around 200 employees Susmita Roy20 Nov 2022 5:11 PM ISTMumbai: In a significant restructuring move, with an aim to cut costs, the pharmaceutical giant, GSK Pharma has decided to terminate its consumer...
CDSCO panel approves GSK pharma's protocol amendment proposal for Mepolizumab Powder for Solution for Injection Dr. Divya Colin20 Nov 2022 3:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major GSK...
Indian Pharma Market registers 7.2 percent growth in October: AIOCD-AWACS Report Farhat Nasim11 Nov 2022 6:00 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has registered a decline in growth for the month of October as industry sales rose only 7.2 percent...
Former Sanofi head Christopher A Viehbacher appointed as Biogen new President, CEO Ruchika Sharma11 Nov 2022 12:30 PM ISTCambridge: Biogen Inc. has announced that its Board of Directors has appointed Christopher A. Viehbacher as President and Chief Executive Officer and...
GSK Consumer, Hindustan Unilever to terminate distribution agreement for OTC products including Crocin Ruchika Sharma10 Nov 2022 4:00 PM ISTAs per the agreements, the one-year notice period for termination shall commence from November 9, 2022, it added.
Setback: GSK blood cancer drug Blenrep fails main goal of superiority trial Ruchika Sharma8 Nov 2022 12:30 PM ISTBlenrep is an antibody drug conjugate comprising a humanised BCMA monoclonal antibody conjugated to the cytotoxic agent auristatin F via non-cleavable...
GSK gets USFDA priority review for RSV older adult vaccine Ruchika Sharma4 Nov 2022 12:15 PM ISTGSK’s RSV older adult vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with GSK’s proprietary...
GSK barred from bulk drug purchasing program in China over prostate drug Avodart quality issues Ruchika Sharma1 Nov 2022 3:30 PM ISTThe exclusion from the VBP programme represents a setback for GSK, which considers China - one of the biggest markets for biopharmaceuticals...
GSK marketing authorisation application for RSV older adult vaccine accepted by EMA under accelerated assessment Ruchika Sharma31 Oct 2022 3:44 PM ISTRespiratory Syncytial Virus is a common contagious virus affecting the lungs and breathing passages.
ViiV Healthcare Cabotegravir long-acting injectable for HIV prevention gets EMA validation Ruchika Sharma30 Oct 2022 11:45 AM ISTCabotegravir long-acting for PrEP is an integrase strand transfer inhibitor (INSTI).
GSK, Tempus enter into expanded collaboration in precision medicine to accelerate RnD Ruchika Sharma25 Oct 2022 9:00 AM ISTLondon: GSK plc and Tempus, a US-based precision medicine company, have entered into a three-year collaboration agreement that provides GSK with...
